Brinter Inc

2:45 PM - 3:00 PM (EST), Tuesday, February 7, 2023 ・ Winter Garden
Brinter is a BioTech/MedTech startup from the US and Finland. Our core business is developing, licensing, and selling our in-house pre-clinical and clinical applications.

Our spearhead applications are cartilaginous bio-implants, wound healing bio-bandages, and solutions for pre-clinical drug discovery & development and complex clinical drug printing with our commercial and patented 3D (bio)printing tech.

Our key partners and customers are clinics, research, and academia, hospitals, CROs, bio, and pharmaceutical companies.

We have $1M in sales (2020-22) from our commercial 3D bioprinters. Previous funding: ~$3M in grants and $1.2M seed round (04/2021).

Our application development is at Wake Forest’s biotech accelerator in NC and business development in California. Tech R&D is in Finland. Our 17 people are mostly bio-scientists and engineers.

Our strategic investors and EXIT opportunities are in MedTech and Pharma industry (GE HealthCare, J&J MedTech, Roche etc.).
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Regenerative Medicine
Lead Product in Development:
CARTILAGINOUS BIO IMPLANTS
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
4
Speaker